In a move reverberating across global healthcare and financial markets, Donald Trump has announced a deal ...
In a move reverberating across global healthcare and financial markets, Donald Trump has announced a deal to cap insulin prices at $25 per month and slash the cost of GLP-1 obesity drugs, calling it a ...